Tavin L Tablet is a combination medication that contains two active ingredients: Lamivudine (300 mg) and Tenofovir disoproxil fumarate (300 mg). This powerful formulation is primarily used in the management of HIV (Human Immunodeficiency Virus) infection and chronic hepatitis B virus infection. Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that works by interfering with the virus’s ability to replicate, while Tenofovir disoproxil fumarate is a nucleotide reverse transcriptase inhibitor that also inhibits viral replication. Together, these components help to reduce the viral load in the body, improve immune function, and prevent the progression of HIV-related diseases. Tavin L Tablet is typically prescribed as part of a comprehensive antiretroviral therapy regimen, making it a crucial option for individuals living with HIV or chronic hepatitis B. Its effectiveness, combined with a favorable safety profile, makes Tavin L a vital tool in the fight against these viral infections.